MURA – Mural Oncology plc
Mural Oncology plcMURA
$4.00Name : Mural Oncology plc
Sector : Healthcare
Industry: Biotechnology
Mark. Cap: $68,241,200.00
EPSttm : -9.02
Mural Oncology plc
$4.00
8.40%$0.31Float Short %
2.8
Margin Of Safety %
Put/Call OI Ratio
0.16
EPS Next Q Diff
-0.09
EPS Last/This Y
4.89
EPS This/Next Y
2.83
Price
4
Target Price
16
Analyst Recom
1
Performance Q
7.53
Relative Volume
1.87
Beta
3.72
Ticker: MURA
of 1
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2024-12-19 | MURA | 3.12 | 0.42 | 999.99 | 931 |
| 2024-12-20 | MURA | 3.15 | 0.46 | 4.20 | 958 |
| 2024-12-23 | MURA | 3.27 | 1.37 | 4.00 | 427 |
| 2024-12-24 | MURA | 3.24 | 1.49 | 0.00 | 521 |
| 2024-12-26 | MURA | 3.16 | 1.49 | 0.14 | 521 |
| 2024-12-27 | MURA | 3.2 | 1.44 | 8.00 | 528 |
| 2024-12-30 | MURA | 3.13 | 1.44 | 8.00 | 528 |
| 2024-12-31 | MURA | 3.24 | 1.66 | 0.00 | 564 |
| 2025-01-02 | MURA | 3.2 | 1.66 | 0.00 | 564 |
| 2025-01-03 | MURA | 3.41 | 1.63 | 0.00 | 568 |
| 2025-01-06 | MURA | 3.43 | 0.49 | 0.00 | 1076 |
| 2025-01-07 | MURA | 3.47 | 0.49 | 0.00 | 1066 |
| 2025-01-08 | MURA | 3.81 | 0.26 | 0.00 | 1708 |
| 2025-01-09 | MURA | 3.65 | 0.26 | 0.00 | 1708 |
| 2025-01-10 | MURA | 3.88 | 0.16 | 0.00 | 2620 |
| 2025-01-13 | MURA | 3.72 | 0.14 | 0.03 | 2937 |
| 2025-01-14 | MURA | 3.71 | 0.14 | 5.88 | 2937 |
| 2025-01-15 | MURA | 3.65 | 0.15 | 6.67 | 2930 |
| 2025-01-16 | MURA | 3.69 | 0.16 | 0.00 | 2970 |
| 2025-01-17 | MURA | 3.99 | 0.16 | 0.15 | 2976 |
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2024-12-19 | MURA | 3.12 | - | - | -7.54 |
| 2024-12-20 | MURA | 3.14 | - | - | -7.54 |
| 2024-12-23 | MURA | 3.29 | - | - | -7.54 |
| 2024-12-24 | MURA | 3.24 | - | - | -7.54 |
| 2024-12-26 | MURA | 3.18 | - | - | -7.54 |
| 2024-12-27 | MURA | 3.20 | - | - | -7.54 |
| 2024-12-30 | MURA | 3.13 | - | - | -7.54 |
| 2024-12-31 | MURA | 3.21 | - | - | -7.54 |
| 2025-01-02 | MURA | 3.20 | - | - | -7.54 |
| 2025-01-03 | MURA | 3.42 | - | - | -7.54 |
| 2025-01-06 | MURA | 3.42 | - | - | -7.54 |
| 2025-01-07 | MURA | 3.47 | - | - | -7.54 |
| 2025-01-08 | MURA | 3.65 | - | - | -7.54 |
| 2025-01-09 | MURA | 3.65 | - | - | -7.54 |
| 2025-01-10 | MURA | 3.89 | - | - | -7.54 |
| 2025-01-13 | MURA | 3.75 | - | - | -7.54 |
| 2025-01-14 | MURA | 3.71 | - | - | -7.54 |
| 2025-01-15 | MURA | 3.69 | - | - | -7.54 |
| 2025-01-16 | MURA | 3.68 | - | - | -7.54 |
| 2025-01-17 | MURA | 4.00 | - | - | -7.54 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2024-12-19 | MURA | -1.30 | -4.44 | 3.07 |
| 2024-12-20 | MURA | -1.30 | -4.44 | 3.07 |
| 2024-12-23 | MURA | -1.29 | -4.44 | 3.07 |
| 2024-12-24 | MURA | -1.29 | -4.44 | 3.07 |
| 2024-12-26 | MURA | -1.47 | -4.44 | 2.89 |
| 2024-12-27 | MURA | -1.47 | -4.44 | 2.89 |
| 2024-12-30 | MURA | -1.45 | -4.44 | 2.89 |
| 2024-12-31 | MURA | -1.45 | -4.44 | 2.89 |
| 2025-01-02 | MURA | -1.44 | -4.44 | 2.89 |
| 2025-01-03 | MURA | -1.47 | -4.44 | 2.89 |
| 2025-01-06 | MURA | -1.38 | -5.09 | 2.89 |
| 2025-01-07 | MURA | -1.38 | -5.09 | 2.89 |
| 2025-01-08 | MURA | -1.47 | -5.09 | 2.89 |
| 2025-01-09 | MURA | -0.66 | -5.09 | 2.89 |
| 2025-01-10 | MURA | -0.66 | -5.09 | 2.89 |
| 2025-01-13 | MURA | -0.66 | -5.09 | 2.80 |
| 2025-01-14 | MURA | -0.66 | -5.09 | 2.80 |
| 2025-01-15 | MURA | -0.66 | -5.09 | 2.80 |
| 2025-01-16 | MURA | -0.66 | -5.09 | 2.80 |
| 2025-01-17 | MURA | -0.66 | -5.09 | 2.80 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
-1.87
Avg. EPS Est. Current Quarter
-1.98
Avg. EPS Est. Next Quarter
-1.96
Insider Transactions
-0.66
Institutional Transactions
-5.09
Beta
3.72
Average Sales Estimate Current Quarter
Average Sales Estimate Next Quarter
Fair Value
Quality Score
5
Growth Score
Sentiment Score
60
Actual DrawDown %
76.5
Max Drawdown 5-Year %
Target Price
16
P/E
Forward P/E
PEG
P/S
P/B
0.39
P/Free Cash Flow
EPS
-9.14
Average EPS Est. Cur. Y
-7.54
EPS Next Y. (Est.)
-4.72
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
Relative Volume
1.87
Return on Equity vs Sector %
-107.4
Return on Equity vs Industry %
-94.8
EPS 1 7Days Diff
EPS 1 30Days Diff
-0.08
EBIT Estimation
Mural Oncology plcSector: Healthcare
Industry: Biotechnology
Employees: 107
Mural Oncology plc, a clinical-stage oncology company, focuses on discovering and developing immunotherapies for the treatment of patients with cancer. The company's lead product candidate includes nemvaleukin alfa for the treatment of mucosal melanoma as a monotherapy and platinum-resistant ovarian cancer in combination with pembrolizumab. It also develops nemvaleukin to treat cutaneous melanoma and advanced solid tumors. The company is also developing engineered interleukin-18 and tumor-targeted interleukin-12 programs. Mural Oncology plc was incorporated in 2017 and is based in Dublin, Ireland.
stock quote shares MURA – Mural Oncology plc Stock Price stock today
news today MURA – Mural Oncology plc stock forecast ,stock prediction 2023 2024 2025
marketwatch MURA – Mural Oncology plc yahoo finance google finance
stock history MURA – Mural Oncology plc invest stock market
stock prices MURA premarket after hours
ticker MURA fair value insiders trading